Quantitative assessment of human serum transferrin receptor in breast cancer patients pre- and post-chemotherapy using peptide immunoaffinity enrichment coupled with targeted proteomics

Clinica Chimica Acta

Volumn 448, Issue , 2015, Pages 118-123

  Xu, Qingqing ^a   Zhu, Mingchen ^b   Yang, Ting ^a   Xu, Feifei ^a   Liu, Yuan ^c   Chen, Yun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b JIANGSU CANCER HOSPITAL   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Chemotherapy; Liquid chromatography tandem mass spectrometry; Serum transferrin receptor; SISCAPA; Targeted proteomics

Indexed keywords

TRANSFERRIN RECEPTOR; ANTINEOPLASTIC AGENT; PEPTIDE;

ADULT; AGED; AMINO ACID SEQUENCE; ANTIBODY AFFINITY; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CONTROLLED STUDY; ENRICHMENT CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; MEASUREMENT PRECISION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PROTEIN DEPLETION; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS; BLOOD; BREAST NEOPLASMS; IMMUNOLOGY; MIDDLE AGED;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; MIDDLE AGED; PEPTIDES; PROTEOMICS; RECEPTORS, TRANSFERRIN; TANDEM MASS SPECTROMETRY;

EID: 84936888692     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2015.05.022     Document Type: Article

References (36)

1. Pfeiffer C.M., Cook J.D., Mei Z., Cogswell M.E., Looker A.C., Lacher D.A. Evaluation of an automated soluble transferrin receptor (sTfR) assay on the Roche Hitachi analyzer and its comparison to two ELISA assays. Clin Chim Acta 2007, 382:112-116.
2. Yoshimoto K. Elevation of soluble transferrin receptor substance in serum of cancer patients with suppressed natural killer activity. Nihon Gan Chiryo Gakkai Shi 1989, 24:2418-2425.
3. Kuvibidila S., Gauthier T., Warrier R.P., Rayford W. Increased levels of serum transferrin receptor and serum transferrin receptor/log ferritin ratios in men with prostate cancer and the implications for body-iron stores. J Lab Clin Med 2004, 144:176-182.
4. Beguin Y. Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta 2003, 329:9-22.
5. Corazza F., Beguin Y., Bergmann P., et al. Anemia in children with cancer is associated with decreased erythropoietic activity and not with inadequate erythropoietin production. Blood 1998, 92:1793-1798.
6. Barnidge D.R., Dratz E.A., Martin T., Bonilla L.E., Moran L.B., Lindall A. Absolute quantification of the G protein-coupled receptor rhodopsin by LC/MS/MS using proteolysis product peptides and synthetic peptide standards. Anal Chem 2003, 75:445-451.
7. Method of the year 2012. Nat Methods 2013, 10:1.
8. Doerr A. Targeted proteomics. Nat Methods 2010, 7:34.
9. Doerr A. Targeted proteomics. Nat Methods 2011, 8:43.
10. Whiteaker J.R., Zhao L., Abbatiello S.E., et al. Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry. Mol Cell Proteomics 2011, 10. [M110 005645].
11. Pan W., Yang H., Zhang T., Li Y., Li N., Tang B. Dual-targeted nanocarrier based on cell surface receptor and intracellular mRNA: an effective strategy for cancer cell imaging and therapy. Anal Chem. 2013, 85:6930-6935.
12. Pasricha S.R., Rooney P., Schneider H. Soluble transferrin receptor and depth of bone marrow suppression following high dose chemotherapy. Support Care Cancer 2009, 17:847-850.
13. Anderson N.L., Anderson N.G., Haines L.R., Hardie D.B., Olafson R.W., Pearson T.W. Mass spectrometric quantitation of peptides and proteins using stable isotope standards and capture by anti-peptide antibodies (SISCAPA). J Proteome Res 2004, 3:235-244.
14. Whiteaker J.R., Zhao L., Zhang H.Y., et al. Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers. Anal Biochem 2007, 362:44-54.
15. Xu F., Yang T., Fang D., Xu Q., Chen Y. An investigation of heat shock protein 27 and P-glycoprotein mediated multi-drug resistance in breast cancer using liquid chromatography-tandem mass spectrometry-based targeted proteomics. J Proteomics. 2014, 108C:188-197.
16. Guidance for Industry: Bioanalytical Method Validation 2001, http://www.fda.gov/downloads/Drugs/Guidances/ucm070107.pdf, US Department of Health and Human Services, Food and Drug Administration.
17. Li N., Palandra J., Nemirovskiy O.V., Lai Y. LC-MS/MS mediated absolute quantification and comparison of bile salt export pump and breast cancer resistance protein in livers and hepatocytes across species. Anal Chem 2009, 81:2251-2259.
18. Yuan Z.-Y., Luo R.-Z., Peng R.-J., Wang S.-S., Xue C. High infiltration of tumor-associated macrophages in triple-negative breast cancer is associated with a higher risk of distant metastasis. OncoTargets and therapy. 2013, 7:1475-1480.
19. Jhaveri M.S., Rait A.S., Chung K.N., Trepel J.B., Chang E.H. Antisense oligonucleotides targeted to the human alpha folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatment. Mol Cancer Ther 2004, 3:1505-1512.
20. Anderson N.L., Anderson N.G. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002, 1:845-867.
21. Liu B., Qiu F.H., Voss C., Xu Y., Zhao M.Z., Wu Y.X., et al. Evaluation of three high abundance protein depletion kits for umbilical cord serum proteomics. Proteome Sci. 2011, 9:24.
22. Gillette M.A., Carr S.A. Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry. Nat Methods. 2013, 10:28-34.
23. Whiteaker J.R., Paulovich A.G. Peptide immunoaffinity enrichment coupled with mass spectrometry for peptide and protein quantification. Clin Lab Med. 2011, 31:385-396.
24. Wind T.C., Messenger M.P., Thompson D., Selby P.J., Banks R.E. Measuring carbonic anhydrase IX as a hypoxia biomarker: differences in concentrations in serum and plasma using a commercial enzyme-linked immunosorbent assay due to influences of metal ions. Ann Clin Biochem. 2011, 48:112-120.
25. Ferrer Amate C., Unterluggauer H., Fischer R.J., Fernandez-Alba A.R., Masselter S. Development and validation of a LC-MS/MS method for the simultaneous determination of aflatoxins, dyes and pesticides in spices. Anal Bioanal Chem. 2014, 397:93-107.
26. van de Merbel N.C. Quantitative determination of endogenous compounds in biological samples using chromatographic techniques. TrAC Trends Anal Chem 2008, 27:924-933.
27. Kowal S., Balsaa P., Werres F., Schmidt T.C. Fully automated standard addition method for the quantification of 29 polar pesticide metabolites in different water bodies using LC-MS/MS. Anal Bioanal Chem. 2013, 405:6337-6351.
28. Song L., Morrison J.J., Botting N.P., Thornalley P.J. Analysis of glucosinolates, isothiocyanates, and amine degradation products in vegetable extracts and blood plasma by LC-MS/MS. Anal Biochem 2005, 347:234-243.
29. Ostroukhova O.K., Zenkevich I.G. A comparison of the external standard and standard addition methods for the quantitative chromatographic determination of pesticide concentrations in plant samples. J Anal Chem 2006, 61:442-451.
30. Raaf H.N., Jacobsen D.W., Savon S., Green R. Serum transferrin receptor level is not altered in invasive adenocarcinoma of the breast. Am J Clin Pathol 1993, 99:232-237.
31. Olufemi A.E., Olatunji M.V., Saliu O.A., Layiwola A.M., Lawrence A.A., Pius O.D. Soluble transferrin receptor discriminates iron deficiency anemia from anemia of chronic disease in leukemic and breast cancer patients. Am J Biomed Sci 2014, 6:6-10.
32. Xu X.S., Demers R., Gu H., Christopher L.J., Su H., Cojocaru L., et al. Liquid chromatography and tandem mass spectrometry method for the quantitative determination of saxagliptin and its major pharmacologically active 5-monohydroxy metabolite in human plasma: method validation and overcoming specific and non-specific binding at low concentrations. J Chromatogr B Analyt Technol Biomed Life Sci. 2012, 889-890:77-86.
33. Cummings J., Zhou C., Dive C. Application of the beta-expectation tolerance interval to method validation of the M30 and M65 ELISA cell death biomarker assays. J Chromatogr B Analyt Technol Biomed Life Sci. 2011, 879:887-893.
34. Whiteaker J.R., Zhao L., Anderson L., Paulovich A.G. An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers. Mol Cell Proteomics. 2010, 9:184-196.
35. Schoenherr R.M., Zhao L., Whiteaker J.R., Feng L.C., Li L., Liu L., et al. Automated screening of monoclonal antibodies for SISCAPA assays using a magnetic bead processor and liquid chromatography-selected reaction monitoring-mass spectrometry. J Immunol Methods. 2010, 353:49-61.
36. Lin D., Alborn W.E., Slebos R.J., Liebler D.C. Comparison of protein immunoprecipitation-multiple reaction monitoring with ELISA for assay of biomarker candidates in plasma. J Proteome Res. 2013, 12:5996-6003.